Skip to content

Therapeutic effect of transcutaneous electrical acupoint stimulation on metastatic pain of vertebral body in patients with tumor

Therapeutic effect of transcutaneous electrical acupoint stimulation on metastatic pain of vertebral body in patients with tumor

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003131
Enrollment
Unknown
Registered
2020-03-07
Start date
2015-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Pain

Interventions

Sponsors

the First People's Hospital of Xiaoshan District
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with tumors confirmed by histopathology; bone metastases confirmed by imaging or biopsy; chronic persistent pain or recurrent paroxysmal pain; aged 18 to 75 years; conscious and able to express subjective feelings; Expected survival time greater than 3 months.

Exclusion criteria

Exclusion criteria: Local skin diseases or skin lesions at acupoints of electroacupuncture; abnormal coagulation with petechiae and petechiae under the skin; hypertension (blood pressure beyond 160 MMHG and DBP above 95 mmhg after taking medication) ; severe cerebrovascular disease such as cerebral hemorrhage, large area cerebral infarction and history of epilepsy; Serious heart disease, such as myocardial infarction, acute coronary syndrome, Arrhythmia and more than 2 levels of cardiac dysfunction, such as the need to take medication; consciousness and speech difficulties, such as Halo Acupuncture history or hypersensitivity to electrical stimulation; Pregnant women and lactating women; Grade 2 or above liver and kidney dysfunction; not according to the provisions of treatment, unable to judge the efficacy or incomplete information such as impact judgment.

Design outcomes

Primary

MeasureTime frame
Pain Score;

Secondary

MeasureTime frame
CD4, CD8 and NK cells;Sleep quality;Anxiety;

Countries

China

Contacts

Public ContactJia-bin Tai

the First People's Hospital of Xiaoshan District

56664798@qq.com+86 15356111149

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026